Cite
MLA Citation
H. Lachmann et al.. “SAT0532 Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF-Receptor Associated Periodic Syndrome (TRAPS).” Annals of the rheumatic diseases, vol. 74, n.d., pp. 852–853. http://access.bl.uk/ark:/81055/vdc_100135144340.0x00004e